Is Small Pharma a Good Psychedelic Stock Investment?
Our resident Psychedelic Investor James Hallifax looks at the pros and cons of this Canadian-based company developing DMT for therapeutic use.
Day: March 18, 2022
-
-
Psychedelic Business Spotlight – March 18
This week in psychedelic business news: A psychedelics company folds; Ketamine Wellness Centers expand; Nova Mentis funds psilocybin studies.
-
Are Celebrities Helping the Psychedelic Movement?
To watch the entire Spotlight In Focus episode, visit: https://www.altrd.tv/shows/spotlight-focus/season/1/episode/2…
